Clinical trials
Primary Myelofibrosis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Terminated | 11 |
| Recruiting | 7 |
| Not yet recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 5 |
| University Hospital, Angers | 4 |
| City of Hope Medical Center | 3 |
| Masonic Cancer Center, University of Minnesota | 3 |
| Roswell Park Cancer Institute | 3 |
| Wake Forest University Health Sciences | 3 |
| Hamad Medical Corporation | 2 |
| M.D. Anderson Cancer Center | 2 |
| OHSU Knight Cancer Institute | 2 |
| University of California, San Francisco | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 59 |
| Myeloproliferative Disorders | 43 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 39 |
| Leukemia, Myeloid, Acute | 37 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 36 |
| Multiple Myeloma | 36 |
| Hodgkin Disease | 35 |
| Lymphoma, Non-Hodgkin | 35 |
| Lymphoma, Mantle-Cell | 34 |
| Lymphoma, Large B-Cell, Diffuse | 33 |
Trials
Showing 26 to 50 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.